Theseus Pharmaceuticals Long Term Debt

Theseus Pharmaceuticals (THRX) currently reports a long-term debt of $2.9M as of September 2023. That compares with $3.3M in the prior-year period — down 13.3% year over year. Use the charts on this page to explore Theseus Pharmaceuticals's long-term debt history and peer comparisons.

Theseus Pharmaceuticals's long-term debt decreased from $3.3M to $2.9M — a 13.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Theseus Pharmaceuticals reported $2.9M in long-term debt as of September 2023. That compares with $3.3M in the prior-year period — down 13.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $2.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Theseus Pharmaceuticals, and consider following THRX for alerts when major investors trade the stock.

Theseus Pharmaceuticals is classified in the Healthcare sector. On long-term debt, it currently shows $2.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing THRX with unrelated industries.